| Wednesday, June 29, 2016 |
|
|
| 6:30 AM–7:30 AM |
Society for Birth Defects Research and Prevention 35TH ANNUAL VOLLEYBALL GAME – Factory of Champions |
| |
|
| 7:00 AM–2:30 PM |
REGISTRATION OPEN – Texas Ballroom Foyer |
| |
|
| 7:00 AM–2:30 PM |
SPEAKER READY ROOM OPEN – Crockett A |
| |
|
| 7:30 AM–8:00 AM |
MORNING COFFEE AND PASTRIES – Texas Ballroom D |
| |
|
| 8:00 AM–8:30 PM |
NARSINGH AGNISH FELLOW LECTURE – Texas Ballroom D |
| |
Educational Convergence of Sciences: Basic-Clinical-Discovery-Regulatory
|
| |
Organized by the Education Committee, Chairperson, Chris J Stodgell, University of Rochester |
| |
Speaker: Richard K. Miller, University of Rochester Medical Center |
| |
|
| 8:30 AM–9:30 AM |
Society for Birth Defects Research and Prevention AND EUROPEAN Society for Birth Defects Research and Prevention EXCHANGE LECTURE – Texas Ballroom D |
| |
GMOs and Glyphosphate |
| |
Chairpersons: Susan L. Makris, US Environmental Protection Agency and Shay Giles, University College, Dublin, Ireland |
| |
Society for Birth Defects Research and Prevention
John M. DeSesso, Exponent, Inc. |
| |
European Society for Birth Defects Research and Prevention
Jochen Buschmann, Fraunhofer Institute for Toxicology and Experimental Medicine |
| |
|
| 9:30 AM–10:30 AM |
SPECIAL REPORT – Texas Ballroom D
|
| |
EXPLORING THE LINK BETWEEN ZIKA VIRUS AND MICROCEPHALY |
| |
Chairpersons: Sonja A. Rasmussen, Centers for Disease Control and Prevention and Tacey E.K. White, Aclairo® Pharmaceutical Development Group, Inc. |
| 9:30 AM–9:35 AM |
|
Introduction |
| |
|
|
| 9:35 AM–9:55 AM |
SR1 |
Exploring the Link between Zika Virus and Microcephaly
|
| |
|
Lavinia Schuler-Faccini, Brazilian Society of Medical Genetics |
| |
|
|
| 9:55 AM–10:15 AM |
SR2 |
Exploring the Link between Zika virus and Adverse Pregnancy and Birth Outcomes |
| |
|
Sonja A. Rasmussen, Centers for Disease Control and Prevention |
| |
|
|
| 10:15 AM–10:30 AM |
|
Discussion |
|
| |
|
| 9:30 AM–12:30 PM |
PLATFORM SESSION 4 – Texas Ballroom E |
| |
Epidemiology
Chairpersons: José F. Cordero, University of Georgia and Peter Langlois, Texas Department of State Health Services |
| |
Presenting author is underlined. |
| 9:30 AM–9:45 AM |
|
Introduction |
| |
|
|
| 9:45 AM–10:00 AM |
27 |
Hair Dye Use and the Risk of Congenital Malformations. Results from a New Zealand Birth Defects Case-Control Study
't Mannetje AM1, Borman B1, Eng AJ1, Ellison-Loschmann L1, Douwes JE1, Pearce N2. 1Centre for Public Health Research, Massey University, Wellington, New Zealand, 2Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom. |
| |
|
|
| 10:00 AM–10:15 AM |
28 |
Maternal and Infant Genetic Variants in Folate, Homocysteine and Trans-Sulfuration Pathways Modify the Association between Prenatal Selective Serotonin Reuptake Inhibitors Use and Risk of Congenital Heart Defects
Nembhard WN1,2, Tang X3,2, Hu Z3,2, MacLeod S1,2, Stowe Z4, Webber D1, The National Birth Defects Prevention Study1. 1Division of Birth Defects Research, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, United States, 2Arkansas Children's Hospital Research Institute, Little Rock, AR, United States, 3Division of Biostatistics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, United States, 4Department of Psychiatry, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, United States. |
| |
|
|
| 10:15 AM–10:30 AM |
29 |
Contribution of Total Prevention of Folic Acid Preventable Spina Bifida and Anencephaly towards Achieving Health-Related Sustainable Development Goals in India
Kancherla V, Oakley GP. Emory University Rollins School of Public Health, Atlanta, GA, United States. |
| |
|
|
| 10:30 AM–11:00 AM |
|
Warkany Tea—Texas Ballroom A |
| |
|
|
| 11:00 AM–11:15 AM |
30 |
Descriptive Epidemiology of Microcephaly in Texas
Canfield MA1, Langlois PH1, Marengo LK1, Hoyt AT1, Ethen MK1, Scheuerle AE2. 1Texas Department of State Health Services, Austin, TX, United States, 2UT Southwestern Medical Center, Dallas, TX, United States. |
| |
|
|
| 11:15 AM–11:30 AM |
31 |
Antidepressant Use in Pregnancy and the Risk of Attention Deficit with or without Hyperactivity Disorder in Children
Boukhris T1,2, Sheehy O2, Berard A1,2. 1Faculty of Pharmacy, University of Montreal, Montreal, QC, Canada, 2Research Center, CHU Sainte-Justine, Montreal, QC, Canada. |
| |
|
|
| 11:30 AM–11:45 AM |
32 |
Multicentric Study of Genetic and Environmental Risk Factors Associated to Myelomeningocele in a Sample of 500 Trios of the Mexican Mestizo Population
Mutchinick OM1, Aguayo A1, Ortiz G1, Muñoz LA1, Luna L1, Sánchez ME1, Berumen E2. 1Genetics Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Mexico, 2Fundación Teletón, Estado de México, Mexico. |
| |
|
|
| 11:45 AM–12:00 Noon |
33 |
Risk of Preterm Birth following Late-Pregnancy Exposure to Medications used in the Treatment of Autoimmune Diseases
Berard A1,2, Sheehy O1, Girard S1,2, Zhao J1. 1Research Center CHU Sainte-Justine, Montreal, QC, Canada, 2University of Montreal, Montreal, QC, Canada. |
| |
|
|
| 12:00 Noon–12:15 PM |
34 |
Folate, Iron, and Choline Intake in Pregnant Women with Substance Use Disorders
Shrestha S1, Jimenez EY2, Cano S1, Williams S1, Stephen JM1, Bakhireva LN1. 1University of New Mexico Health Sciences Center and the Mind Research Network, Albuquerque, NM, United States, 2Center for Education Policy Research, University of New Mexico, Albuquerque, NM, United States. |
| |
|
|
| 12:15 PM–12:30 PM |
35 |
Indoor Air Pollution and Orofacial Clefts in a Rural Population of Northern China
Liu Y, Li Z, Wang B, Ren A. Institute of Reproductive and Child Health, Ministry of Health Key Laboratory of Reproductive Health, Peking University, Beijing, China. |
|
| |
|
| 10:30 AM–11:00 AM |
WARKANY TEA – Texas Ballroom A |
| |
|
| 11:00 AM–12:30 PM |
STRATEGIES FOR POSTAPPROVAL ASSESSMENT
WORKSHOP – Texas Ballroom D |
| |
Chairpersons: Cheryl S. Broussard, Centers for Disease Control and Prevention and Melissa S. Tassinari, US Food and Drug Administration |
| 11:00 AM–11:05 AM |
|
Introduction |
| |
|
|
| 11:05 AM–11:25 AM |
W8 |
What Do You Need to Consider When Designing an Approach to Data Collection to Maximize Success in Collection of Exposures and Outcomes |
| |
|
Sara Ephross, Consultant |
| |
|
|
| 11:25 AM–11:45 AM |
W9 |
BD-STEPS: The Next Generation of Birth Defects Research |
| |
|
Cheryl S. Broussard, Centers for Disease Control and Prevention |
| |
|
|
| 11:45 AM–12:05 PM |
W10 |
What is US Food and Drug Administration Looking for to Assess and Label Risk? |
| |
|
Lockwood Taylor, US Food and Drug Administration |
| |
|
|
| 12:05 PM–12:25 PM |
W11 |
New Approaches to the Design and Analysis of Studies Evaluating Drug Safety during Pregnancy
|
| |
|
Krista Huybrechts, Harvard Medical School |
| |
|
|
| 12:25 PM–12:30 PM |
|
Discussion |
|
| |
|
| 12:30 PM–1:30 PM |
LUNCH ON YOUR OWN |
| |
|
| 12:30 PM–1:30 PM |
EDUCATION COMMITTEE MEETING – Republic A |
| |
|
| 12:30 PM–1:30 PM |
MEMBERSHIP COMMITTEE MEETING – Crockett B |
| |
|
| 12:30 PM–1:30 PM |
SCIENCE AND PUBLIC POLICY WORKSHOP: HOW IT AFFECTS YOU AND HOW YOU CAN SHAPE IT – Texas Ballroom D |
| |
Chairpersons: Wafa A. Harrouk, US Food and Drug Administration and Belen Tornesi, AbbVie Inc. |
| |
|
| 12:30 PM–12:35 PM |
W12 |
Introduction |
| |
|
|
| 12:35 PM–12:50 PM |
|
How FASEB Amplifies the Voice of Working Scientists |
| |
|
Howard H. Garrison, Federation of American Societies for Experimental Biology |
| |
|
|
| 12:50 PM–1:05 PM |
|
How FASEB Speaks to the Nation's Leaders |
| |
|
Hudson H. Freeze, Federation of American Societies for Experimental Biology |
| |
|
|
| 1:05 PM–1:20 PM |
|
Society for Birth Defects Research and Prevention Engagement in FASEB |
| |
|
Belen Tornesi, AbbVie Inc. |
| |
|
|
| 1:20 PM–1:30 PM |
|
Discussion |
|
| |
|
| 1:30 PM–4:30 PM |
ASSESSING THE DEVELOPMENTAL TOXICITY OF NANOMATERIALS SYMPOSIUM – Texas Ballroom D |
| |
Chairpersons: Julia M. Gohlke, Virginia Tech and Susan L. Makris, US Environmental Protection Agency |
| 1:30 PM–1:35 PM |
|
Introduction |
| |
|
|
| 1:35 PM–2:15 PM |
S41 |
An Overview of Developmental Toxicity Testing for Nanomaterials |
| |
|
Karin Hougaard, National Research Center for the Working Environment |
| |
|
|
| 2:15 PM–2:55 PM |
S42 |
Inhaled Cadmium Oxide Nanoparticles during Pregnancy Alters Fetal Development and Neonatal Growth in a Mouse Model |
| |
|
Jason L. Blum, New York University School of Medicine |
| |
|
|
| 2:55 PM–3:10 PM |
|
Break – Texas Ballroom A |
| |
|
|
| 3:10 PM–3:50 PM |
S43 |
Maternal Gestational Nanomaterial Exposures: Uterine and Fetal Microvascular Consequences |
| |
|
Timothy R. Nurkiewicz, West Virginia University School of Medicine |
| |
|
|
| 3:50 PM–4:30 PM |
S44 |
Overview of Nanomaterial Regulation: Data Gaps and Research Needs for Risk Assessment |
| |
|
Maureen Gwinn, Office of Research and Development, USEPA |
|
| |
|
| 1:30 PM–4:30 PM |
ILSI HESI SYMPOSIUM – Texas Ballroom E |
| |
Ontogeny of the FcRn in Gestation across Species: Implications for Monoclonal Antibody Developmental Toxicity Testing and Human Risk Assessment |
| |
Chairpersons: William J. Breslin, Eli Lilly and Company and Graeme J. Moffat, Amgen, Inc. |
| 1:30 PM–1:35 PM |
S45 |
Introduction |
| |
|
|
| 1:35 PM–2:25 PM |
S46 |
Cross-Species Ontogeny of Placental Fc Receptors: What We Think We Know and What We Know We Don’t
|
| |
|
John M. DeSesso, Exponent |
| |
|
|
| 2:25 PM–3:00 PM |
S47 |
Ontogeny of FcRn in Gestation across Nonclinical Species |
| |
|
Susan Bielmeier Laffan, GlaxoSmithKline |
| |
|
|
| 3:00 PM–3:15 PM |
|
Break – Texas Ballroom A |
| |
|
|
| 3:15 PM–3:45 PM |
S48 |
FcRn Expression in Human Placenta during Fetal Development
|
| |
|
Susan Westmoreland, AbbVie Inc. |
| |
|
|
| 3:45 PM–4:15 PM |
S49 |
Placental and Yolk Sac FcRn Expression Complements Available Data on Transfer of Specific Fc-Containing Biopharmaceuticals to Inform Nonclinical to Clinical Translation of Developmental Toxicity Data |
| |
|
Lakshmi Sivaraman, Bristol-Myers Squibb Company |
| |
|
|
| 4:15 PM–4:30 PM |
|
Discussion |
|
| |
|
| 4:30 PM–5:15 PM |
CONTINUING MEDICAL EDUCATION (CME) CLOSEOUT–Texas Ballroom Foyer
|
| |
(Staff will be available to collect CME evaluation
forms and hand out CME certificates.) |
| |
|
| 4:45 PM–6:15 PM |
BUSINESS MEETING – Texas Ballroom D |
| |
|
| 6:30 PM–7:30 PM |
BANQUET RECEPTION – Texas Ballroom A |
| |
|
| 7:30 PM–11:00 PM |
BANQUET – Texas Ballroom B |
|
Travel Awards
James C. Bradford Memorial Student Poster Awards
Wilson Presentation Awards
Marie W. Taubeneck Award
Edward W. Carney Trainee Award
Birth Defects Research Distinguished Scholar Awards
Edward W. Carney Distinguished Service Award
Recognition of Other Awards Presented throughout the Week
|
|
|
